How much is Tango Therapeutics worth in 2026?

Tango Therapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Tango Therapeutics raised?

Tango Therapeutics has raised N/A in total funding across 1 funding rounds.

Tango Therapeutics

Drug Discovery

Tango Therapeutics valuation and funding history | Last updated: August 10, 2021 | 1 funding rounds

Current Valuation

N/A

As of August 10, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$186.0M

Last Funding

Aug 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 10, 2021	PIPE	$186.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Tango Therapeutics is currently valued at N/A as of August 10, 2021.

Track Tango Therapeutics Valuation Updates

Get notified when Tango Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Tango Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Tango Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Tango Therapeutics Worth in 2026?

Tango Therapeutics is a leading private company in the Drug Discovery sector. Track Tango Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Tango Therapeutics Valuation is Determined

Private company valuations like Tango Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.